Table 1 Differences between LVNC patients and controls
Controls | LVNC | Chi square | |
n = 155 | n = 100 | ||
Male | 95 (61.3%) | 56 (56.0%) | 0.401 |
Female | 60 (38.7%) | 44 (44.0%) | |
LVEF < 50% | 37 (23.9%) | 48 (48.0%) | <0.001 |
OK | 79 (51.0%) | 0 (0.0%) | <0.001 |
LVNC | 0 (0.0%) | 100 (100.0%) | |
DCM | 27 (17.4%) | 0 (0.0%) | |
HCM | 33 (21.3%) | 0 (0.0%) | |
ARVD | 5 (3.2%) | 0 (0.0%) | |
HHD | 6 (3.9%) | 0 (0.0%) | |
MCD | 5 (3.2%) | 0 (0.0%) | |
Controls | LVNC | Mann-Whitney | |
n = 155 | n = 100 | ||
Age (years) | 48.2 ± 15.4 | 45.5 ± 17.8 | 0.180 |
LA (cm2) | 26.9 ± 8.6 | 25.6 ± 6.4 | 0.333 |
RA (cm2) | 24.6 ± 7.6 | 23.1 ± 6.2 | 0.155 |
LVEDD (cm) | 5.4 ± 1.0 | 5.7 ± 0.8 | <0.001 |
IVS (cm) | 1.2 ± 0.4 | 1.0 ± 0.2 | 0.001 |
EDV (mL) | 160.3 ± 78.7 | 169.4 ± 61.3 | 0.036 |
ESV (mL) | 79.4 ± 76.4 | 95.9 ± 69.1 | <0.001 |
SV (mL) | 84.4 ± 45.7 | 78.5 ± 25.6 | 0.244 |
LVEF (%) | 55.3 ± 15.2 | 48.2 ± 12.7 | <0.001 |
MM (gram) | 122.2 ± 48.5 | 106.0 ± 36.3 | 0.006 |